Medifast Statistics
Total Valuation
Medifast has a market cap or net worth of $112.13 million. The enterprise value is -$49.54 million.
Important Dates
The last earnings date was Monday, November 3, 2025, after market close.
| Earnings Date | Nov 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Medifast has 10.28 million shares outstanding. The number of shares has increased by 0.27% in one year.
| Current Share Class | 10.28M |
| Shares Outstanding | 10.28M |
| Shares Change (YoY) | +0.27% |
| Shares Change (QoQ) | -0.62% |
| Owned by Insiders (%) | 3.01% |
| Owned by Institutions (%) | 84.29% |
| Float | 9.17M |
Valuation Ratios
The trailing PE ratio is 546.73.
| PE Ratio | 546.73 |
| Forward PE | n/a |
| PS Ratio | 0.27 |
| Forward PS | 0.32 |
| PB Ratio | 0.51 |
| P/TBV Ratio | 0.52 |
| P/FCF Ratio | 172.93 |
| P/OCF Ratio | 15.53 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.45, with a Debt / Equity ratio of 0.06.
| Current Ratio | 4.45 |
| Quick Ratio | 3.71 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.48 |
| Debt / FCF | 18.98 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 0.12% and return on invested capital (ROIC) is 1.88%.
| Return on Equity (ROE) | 0.12% |
| Return on Assets (ROA) | 1.52% |
| Return on Invested Capital (ROIC) | 1.88% |
| Return on Capital Employed (ROCE) | 3.07% |
| Revenue Per Employee | $852,569 |
| Profits Per Employee | $492 |
| Employee Count | 504 |
| Asset Turnover | 1.54 |
| Inventory Turnover | 3.74 |
Taxes
In the past 12 months, Medifast has paid $1.77 million in taxes.
| Income Tax | 1.77M |
| Effective Tax Rate | 87.71% |
Stock Price Statistics
The stock price has decreased by -40.74% in the last 52 weeks. The beta is 0.50, so Medifast's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | -40.74% |
| 50-Day Moving Average | 12.69 |
| 200-Day Moving Average | 13.47 |
| Relative Strength Index (RSI) | 34.32 |
| Average Volume (20 Days) | 203,848 |
Short Selling Information
The latest short interest is 2.04 million, so 19.85% of the outstanding shares have been sold short.
| Short Interest | 2.04M |
| Short Previous Month | 2.09M |
| Short % of Shares Out | 19.85% |
| Short % of Float | 22.26% |
| Short Ratio (days to cover) | 13.83 |
Income Statement
In the last 12 months, Medifast had revenue of $429.70 million and earned $248,000 in profits. Earnings per share was $0.02.
| Revenue | 429.70M |
| Gross Profit | 311.27M |
| Operating Income | 6.80M |
| Pretax Income | 2.02M |
| Net Income | 248,000 |
| EBITDA | 20.76M |
| EBIT | 6.80M |
| Earnings Per Share (EPS) | $0.02 |
Full Income StatementBalance Sheet
The company has $173.51 million in cash and $12.26 million in debt, giving a net cash position of $161.25 million or $15.69 per share.
| Cash & Cash Equivalents | 173.51M |
| Total Debt | 12.26M |
| Net Cash | 161.25M |
| Net Cash Per Share | $15.69 |
| Equity (Book Value) | 214.71M |
| Book Value Per Share | 20.89 |
| Working Capital | 161.13M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $7.19 million and capital expenditures -$6.55 million, giving a free cash flow of $646,000.
| Operating Cash Flow | 7.19M |
| Capital Expenditures | -6.55M |
| Free Cash Flow | 646,000 |
| FCF Per Share | $0.06 |
Full Cash Flow StatementMargins
Gross margin is 72.44%, with operating and profit margins of 1.58% and 0.06%.
| Gross Margin | 72.44% |
| Operating Margin | 1.58% |
| Pretax Margin | 0.47% |
| Profit Margin | 0.06% |
| EBITDA Margin | 4.83% |
| EBIT Margin | 1.58% |
| FCF Margin | 0.15% |
Dividends & Yields
Medifast does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.27% |
| Shareholder Yield | -0.27% |
| Earnings Yield | 0.22% |
| FCF Yield | 0.58% |
Dividend DetailsAnalyst Forecast
The average price target for Medifast is $16.50, which is 51.24% higher than the current price. The consensus rating is "Hold".
| Price Target | $16.50 |
| Price Target Difference | 51.24% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medifast has an Altman Z-Score of 5.12 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.12 |
| Piotroski F-Score | 5 |
